Keyuan Pharma held a special meeting on the new product introduction and existing product improvement to accelerate the strategic products layout!

In order to enhance core competitiveness and meet market demand, Keyuan Pharma organized a special meeting on the new product introduction and existing product improvement on February 4. The meeting focused on the strategy of "one body, two wings and three pillars", and discussions on new product plan and existing product improvement to promote the transformation and upgrading.

The meeting focused on hypoglycemic, cardiovascular, anesthetics and other core product areas, discussion on special raw materials, excipients, intermediates and other new product plan. Experts and representatives had exchanges on the R&D direction, market prospects, and technical difficulties, clarified the core advantages and future development direction.

Keyuan Pharma will give full play to own advantages, strengthen cooperation with research institutes, introduce and promote the concepts and technologies of digital intelligence manufacturing from the R&D stage to the final commercial operation, and gather new quality productivity. At the same time, improve production efficiency and quality by introducing advanced technology and equipment, and strengthen team building to provide solid talent guarantee for the sustainable development.

In order to promote the strategic new product layout, Keyuan Pharma will increase investment. On the basis of stable growth of existing products, focus on promoting new product R&D and market promotion, enhance international influence, highlight the responsibility, mission and commitment, and pursue the maximization of shareholders' interests.

In the future, Keyuan Pharma will adhere to the strategies of long-termism, productism, and internationalization, take the budget as the starting point, profit as the guide, R&D as the engine, and system as the guarantee, focus on the integration of raw materials and preparations, the integration of excipients and preparations, continue to reduce cost and improve efficiency to accelerate intelligent manufacture, and accelerate the new product introduction to inject strong impetus into the long-term development.

This meeting marks that Keyuan Pharma has taken a solid step in enhancing core competitiveness and meeting market demand. Keyuan Pharma will continue to uphold the development concept of innovation, pragmatism, and efficiency, achieving higher quality and efficiency development, creating greater value for shareholders and society.